Key points are not available for this paper at this time.
This study classifies blinding methods and provides a detailed description of methods that could overcome some barriers of blinding in clinical trials assessing nonpharmacological treatment, and provides information for readers assessing the quality of results of such trials.
Boutron et al. (Thu,) studied this question.